Holen Sie sich die Stockscreener-App
0.6879
0.52%
-0.0036
Handel nachbörslich:
.68
-0.0079
-1.15%
Schlusskurs vom Vortag:
$0.6915
Offen:
$0.698
24-Stunden-Volumen:
498.68K
Relative Volume:
0.65
Marktkapitalisierung:
$40.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-123.46M
KGV:
-0.2656
EPS:
-2.59
Netto-Cashflow:
$-104.11M
1W Leistung:
+18.66%
1M Leistung:
+51.02%
6M Leistung:
+98.36%
1J Leistung:
-60.91%
1-Tages-Spanne:
$0.6712
$0.7499
1-Wochen-Bereich:
$0.5751
$0.75
52-Wochen-Spanne:
$0.2601
$2.525
Bioatla Inc Stock (BCAB) Company Profile
Firmenname
Bioatla Inc
Sektor
Branche
Telefon
858-558-0708
Adresse
11085 TORREYANA ROAD, SAN DIEGO
Vergleichen Sie BCAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.6879 | 40.61M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Bioatla Inc Stock (BCAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-05-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-28 | Eingeleitet | ROTH Capital | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | BTIG Research | Buy |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-01-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Bioatla Inc Aktie (BCAB) Neueste Nachrichten
Should you wait for a breakout in BioAtla Inc.July 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
Will BioAtla Inc. stock keep outperforming rivalsEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Real time alert setup for BioAtla Inc. performance2025 Volatility Report & Precise Swing Trade Entry Alerts - newser.com
Can momentum traders help lift BioAtla Inc.July 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Detecting price anomalies in BioAtla Inc. with AIWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com
Can technical indicators confirm BioAtla Inc.’s reversalTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Why BioAtla Inc. stock could outperform in 2025Earnings Recap Summary & Risk Managed Investment Entry Signals - newser.com
Historical volatility pattern of BioAtla Inc. visualizedForecast Cut & Long Hold Capital Preservation Tips - newser.com
How to track smart money flows in BioAtla Inc.Index Update & Precise Buy Zone Tips - newser.com
Why BioAtla Inc. stock is rated strong buyWeekly Risk Summary & Daily Oversold Bounce Ideas - newser.com
Will BioAtla Inc. stock recover after recent drop2025 Trading Volume Trends & Daily Stock Trend Watchlist - newser.com
What drives BioAtla Inc stock priceUtilities Sector Analysis & Free Daily Market Summary and Trend Reports - earlytimes.in
What analysts say about BioAtla Inc stockStock Market Trends & Learn What Analysts Rate “Strong Buy” - earlytimes.in
What MACD signals say about BioAtla Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com
Real time social sentiment graph for BioAtla Inc.Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
Finanzdaten der Bioatla Inc-Aktie (BCAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):